Novavax Analyst Says COVID-19 Vaccine Could Net $400M In Yearly Sales
June 29, 2020 at 15:50 PM EDT
Novavax, Inc. shares are on a dream run this year amid catalysts including its COVID-19 vaccine program.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|